ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 300

$1.05M Total Retail Price of All Prescriptions

Rank: 8 out of 300

875 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 875 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 12,169 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 647 481 1 2
METOPROLOL SUCCINATE 633 527 2 6
SIMVASTATIN 625 547 3 5
LEVOTHYROXINE SODIUM 606 552 4 9
CARVEDILOL 530 414 5 12
LISINOPRIL 510 429 6 4
ATORVASTATIN CALCIUM 500 398 7 14
FUROSEMIDE 358 286 8 3
METOPROLOL TARTRATE 318 272 9 13
AMIODARONE HCL 316 259 10 96
HYDROCODONE-ACETAMINOPHEN 295 172 S3 11 1
CLOPIDOGREL 294 237 12 18
ZETIA 282 191 13 109
ATENOLOL 272 255 14 31
ISOSORBIDE MONONITRATE ER 257 217 15 32
VYTORIN 248 221 16 154
CRESTOR 240 182 17 26
POTASSIUM CHLORIDE 238 194 18 22
METFORMIN HCL 235 181 19 19
RANEXA 222 133 20 124
ZOLPIDEM TARTRATE 220 196 21 21
PLAVIX 204 161 22 24
WARFARIN SODIUM 203 163 23 10
NEXIUM 186 148 24 17
PRADAXA 173 172 25 108
PRAVASTATIN SODIUM 164 147 26 15
HYDROCHLOROTHIAZIDE 151 117 27 20
AMLODIPINE BESYLATE-BENAZEPRIL 146 125 28 52
LOVAZA 146 88 28 129
OMEPRAZOLE 133 96 30 11
PANTOPRAZOLE SODIUM 132 124 31 35
LOSARTAN POTASSIUM 127 102 32 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 112 33 64
GABAPENTIN 123 102 34 7
DIOVAN 122 95 35 46
FENOFIBRATE 120 97 36 98
ESCITALOPRAM OXALATE 110 76 37 78
BENAZEPRIL HCL 97 85 38 73
SPIRONOLACTONE 94 66 39 92
NITROSTAT 92 66 40 157
TORSEMIDE 91 53 41 188
RAMIPRIL 87 56 42 63
SOTALOL 86 83 43 133
DIOVAN HCT 82 70 44 94
CITALOPRAM HBR 79 73 45 54
EXFORGE HCT 77 69 46 317
SYNTHROID 70 55 47 49
DICYCLOMINE HCL 70 59 47 193
THEO-24 66 51 49 394
MIDODRINE HCL 65 63 50 298
TRAMADOL HCL 64 55 51 23
CYMBALTA 64 28 51 37
SERTRALINE HCL 61 53 53 41
LORAZEPAM 58 50 54 413
COREG CR 57 42 55 277
ALPRAZOLAM 56 49 56 88
TAMSULOSIN HCL 54 50 57 8
ALLOPURINOL 53 37 58 44
EXFORGE 52 45 59 175
MULTAQ 52 52 59 177
THEOPHYLLINE ANHYDROUS 51 38 61 439
FLUOXETINE HCL 51 44 61 117
PREDNISONE 50 37 63 33
SPIRIVA 50 44 63 84
AZITHROMYCIN 50 38 63 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.